Literature DB >> 19480017

Validity of low copy number typing and applications to forensic science.

Bruce Budowle1, Arthur J Eisenberg, Angela van Daal.   

Abstract

Low copy number (LCN) typing, particularly for current short tandem repeat (STR) typing, refers to the analysis of any sample that contains less than 200 pg of template DNA. Generally, LCN typing simply can be defined as the analysis of any DNA sample where the results are below the stochastic threshold for reliable interpretation. There are a number of methodologies to increase sensitivity of detection to enable LCN typing. These approaches encompass modifications during the polymerase chain reaction (PCR) and/or post-PCR manipulations. Regardless of the manipulations, when processing a small number of starting templates during the PCR exaggerated stochastic sampling effects will occur. The result is that several phenomena can occur: a substantial imbalance of 2 alleles at a given heterozygous locus, allelic dropout, or increased stutter. With increased sensitivity of detection there is a concomitant increased risk of contamination. Recently, a commission reviewed LCN typing and found it to be "robust" and "fit for purpose." Because LCN analysis by its nature is not reproducible, it cannot be considered as robust as that associated with conventional DNA typing. The findings of the commission seem inconsistent with the nature of LCN typing. While LCN typing is appropriate for identification of missing persons and human remains and for developing investigative leads, caution should be taken with its use in other endeavors until developments are made that overcome the vagaries of LCN typing. A more in-depth evaluation by the greater scientific community is warranted. The issues to consider include: training and education, evidence handling and collection procedures, the application or purpose for which the LCN result will be used, the reliability of current LCN methods, replicate analyses, interpretation and uncertainty, report writing, validation requirements, and alternate methodologies for better performance.

Entities:  

Mesh:

Year:  2009        PMID: 19480017      PMCID: PMC2702736          DOI: 10.3325/cmj.2009.50.207

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  36 in total

1.  Commentary on: Budowle B, Onorato AJ, Callaghan TF, Della Manna A, Gross AM, Guerrieri RA, Luttman JC, McClure DL. Mixture interpretation: defining the relevant features for guidelines for the assessment of mixed DNA profiles in forensic casework. J Forensic Sci 2009;54(4):810-21.

Authors:  Peter Gill; John Buckleton
Journal:  J Forensic Sci       Date:  2010-01       Impact factor: 1.832

2.  Commentary on: Budowle B, Bottrell MC, Bunch SG, Fram R, Harrison D, Meagher S, Oien CT, Peterson PE, Seiger DP,Smith MB, Smrz MA, Soltis GL, Stacey RB. A perspective on errors, bias, and interpretation in the forensic sciences and direction for continuing advancement. J Forensic Sci 2009;54(4):798-809.

Authors:  Dan E Krane; Simon Ford; Jason R Gilder; Keith Inman; Allan Jamieson; Roger Koppl; Irving L Kornfield; D Michael Risinger; Norah Rudin; Marc Scott Taylor; William C Thompson
Journal:  J Forensic Sci       Date:  2010-01       Impact factor: 1.832

3.  LoComatioN: a software tool for the analysis of low copy number DNA profiles.

Authors:  Peter Gill; Amanda Kirkham; James Curran
Journal:  Forensic Sci Int       Date:  2006-06-08       Impact factor: 2.395

4.  Simplified low-copy-number DNA analysis by post-PCR purification.

Authors:  Pamela J Smith; Jack Ballantyne
Journal:  J Forensic Sci       Date:  2007-06-06       Impact factor: 1.832

5.  Direct comparison of post-28-cycle PCR purification and modified capillary electrophoresis methods with the 34-cycle "low copy number" (LCN) method for analysis of trace forensic DNA samples.

Authors:  Luke Forster; Jim Thomson; Stefan Kutranov
Journal:  Forensic Sci Int Genet       Date:  2008-06-13       Impact factor: 4.882

6.  National recommendations of the Technical UK DNA working group on mixture interpretation for the NDNAD and for court going purposes.

Authors:  Peter Gill; Rosalind M Brown; Martin Fairley; Lara Lee; Maureen Smyth; Neil Simpson; Brian Irwin; Jim Dunlop; Matt Greenhalgh; Kerry Way; Emma J Westacott; Steven Jon Ferguson; Lisa Victoria Ford; Tim Clayton; June Guiness
Journal:  Forensic Sci Int Genet       Date:  2007-10-22       Impact factor: 4.882

7.  The German Stain Commission: recommendations for the interpretation of mixed stains.

Authors:  P M Schneider; R Fimmers; W Keil; G Molsberger; D Patzelt; W Pflug; T Rothämel; H Schmitter; H Schneider; B Brinkmann
Journal:  Int J Legal Med       Date:  2008-07-05       Impact factor: 2.686

8.  Development and validation of the AmpFlSTR MiniFiler PCR Amplification Kit: a MiniSTR multiplex for the analysis of degraded and/or PCR inhibited DNA.

Authors:  Julio J Mulero; Chien Wei Chang; Robert E Lagacé; Dennis Y Wang; Jennifer L Bas; Timothy P McMahon; Lori K Hennessy
Journal:  J Forensic Sci       Date:  2008-07       Impact factor: 1.832

9.  TWGDAM validation of a nine-locus and a four-locus fluorescent STR multiplex system.

Authors:  K A Micka; E A Amiott; T L Hockenberry; C J Sprecher; A M Lins; D R Rabbach; J A Taylor; J W Bacher; D E Glidewell; S D Gibson; C A Crouse; J W Schumm
Journal:  J Forensic Sci       Date:  1999-11       Impact factor: 1.832

Review 10.  Forensically relevant SNP classes.

Authors:  Bruce Budowle; Angela van Daal
Journal:  Biotechniques       Date:  2008-04       Impact factor: 1.993

View more
  38 in total

1.  Assessment of DNA degradation and the genotyping success of highly degraded samples.

Authors:  Sheree R Hughes-Stamm; Kevin J Ashton; Angela van Daal
Journal:  Int J Legal Med       Date:  2010-04-24       Impact factor: 2.686

2.  Modeling one complete versus triplicate analyses in low template DNA typing.

Authors:  Jianye Ge; Bruce Budowle
Journal:  Int J Legal Med       Date:  2013-10-05       Impact factor: 2.686

3.  Magnitude-dependent variation in peak height balance at heterozygous STR loci.

Authors:  Jason R Gilder; Keith Inman; William Shields; Dan E Krane
Journal:  Int J Legal Med       Date:  2010-02-10       Impact factor: 2.686

4.  Development and validation of I-DNA1: a 15-Loci multiplex system for identity testing.

Authors:  A Odriozola; J M Aznar; D Celorrio; M L Bravo; J J Builes; J F Val-Bernal; Marian M de Pancorbo
Journal:  Int J Legal Med       Date:  2011-01-22       Impact factor: 2.686

5.  Reduced reaction volumes and increased Taq DNA polymerase concentration improve STR profiling outcomes from a real-world low template DNA source: telogen hairs.

Authors:  Dennis McNevin; Janette Edson; James Robertson; Jeremy J Austin
Journal:  Forensic Sci Med Pathol       Date:  2015-05-22       Impact factor: 2.007

6.  Isolating cells from female/male blood mixtures using florescence in situ hybridization combined with low volume PCR and its application in forensic science.

Authors:  Lei Feng; Cai-Xia Li; Jun-Ping Han; Cheng Xu; Lan Hu
Journal:  Int J Legal Med       Date:  2014-11-14       Impact factor: 2.686

7.  Pressure cycling technology (PCT) reduces effects of inhibitors of the PCR.

Authors:  Pamela L Marshall; Jonathan L King; Nathan P Lawrence; Alexander Lazarev; Vera S Gross; Bruce Budowle
Journal:  Int J Legal Med       Date:  2012-09-18       Impact factor: 2.686

8.  An evaluation of the transfer of saliva-derived DNA.

Authors:  David H Warshauer; Pamela Marshall; Shamika Kelley; Jonathan King; Bruce Budowle
Journal:  Int J Legal Med       Date:  2012-07-15       Impact factor: 2.686

9.  An information gap in DNA evidence interpretation.

Authors:  Mark W Perlin; Alexander Sinelnikov
Journal:  PLoS One       Date:  2009-12-16       Impact factor: 3.240

10.  Molecular genetic identification of skeletal remains from the Second World War Konfin I mass grave in Slovenia.

Authors:  Irena Zupanic Pajnic; Barbara Gornjak Pogorelc; Joze Balazic
Journal:  Int J Legal Med       Date:  2010-03-10       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.